Form 4: Roivant Sciences CEO Matthew Gline Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Matthew Gline, CEO of Roivant Sciences, reports the disposal of shares to cover tax obligations related to vested RSUs.
Summary
- On May 20, 2025, Matthew Gline, CEO of Roivant Sciences Ltd., disposed of 10,945 common shares to satisfy tax withholding obligations related to the vesting and settlement of previously granted RSUs.
- The transaction was executed at a price of $11.04 per share.
- Following the transaction, Gline directly owns 17,283,766 common shares of Roivant Sciences Ltd.
Sentiment
Score: 6
Explanation: Neutral sentiment as the filing reflects a routine transaction for tax purposes. It doesn't indicate a significant shift in the CEO's confidence in the company.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of the transaction where shares were disposed of to cover tax obligations. |
| 05/22/2025 | Date of signature by Attorney-in-Fact for Matthew Gline. |
Keywords
Roivant Sciences, Matthew Gline, Form 4, Share Disposal, RSUs, Tax Obligations, Beneficial Ownership, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.